These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Double-blind cross-over evaluation of mazindol in the treatment of obese hypertensive patients.
    Author: Miach PJ, Thomson W, Doyle AE, Louis WJ.
    Journal: Med J Aust; 1976 Sep 04; 2(10):378-80. PubMed ID: 792640.
    Abstract:
    The effect of mazindol (AN 448) on weight and blood pressure was evaluated in a double-blind cross-over trial in 28 obese hypertensive patients, whose blood pressure was under stable control with one or more of the common antihypertensive agents--diuretics, beta-blocking drugs and methyldopa. There was a statistically significant decrease in weight, but no significant change in blood pressure (systolic and diastolic) or pulse rate during active treatment. It was considered that the drug might be of benefit to some patients, provided that they were properly motivated to adhere to the dietary regime.
    [Abstract] [Full Text] [Related] [New Search]